atrasentan has been researched along with Fibrosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Aubert, JD; Juillerat-Jeanneret, L | 1 |
| Baelde, HJ; Bajema, IM; Bos, M; Bruijn, JA; Dijkstra, KL; van Aanhold, CCL; van den Berg, BM; Wolterbeek, R | 1 |
| Lin, L; Liu, Y; Tan, RJ; Zhou, D; Zhou, L | 1 |
| Chang, NC; Chung, TH; Lee, TM; Lin, SZ | 1 |
| Liu, KD | 1 |
| Chen, CC; Hsu, YJ; Lee, TM | 1 |
| Brunner, F; Kirchengast, M; Pang, X; Stessel, H; Wölkart, G | 1 |
| Ammarguellat, F; Larouche, I; Schiffrin, EL | 1 |
2 review(s) available for atrasentan and Fibrosis
| Article | Year |
|---|---|
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrosis; Humans; Hypertension, Pulmonary; Neoplasms; Receptors, Endothelin | 2016 |
Therapeutic strategies for clinical trials targeting renal recovery.
Topics: Acute Kidney Injury; Animals; Atrasentan; Biomarkers; Caloric Restriction; Clinical Trials as Topic; Disease Models, Animal; Fibrosis; Follow-Up Studies; Humans; Inflammation; Kidney; Kidney Function Tests; Mesenchymal Stem Cell Transplantation; Meta-Analysis as Topic; Pyrrolidines; Recovery of Function; Regeneration; Renal Insufficiency, Chronic; Renal Replacement Therapy; Respiratory Distress Syndrome; Risk Factors; Treatment Outcome | 2014 |
6 other study(ies) available for atrasentan and Fibrosis
| Article | Year |
|---|---|
Reduced Glomerular Endothelial Thrombomodulin Is Associated with Glomerular Macrophage Infiltration in Diabetic Nephropathy.
Topics: Animals; Atrasentan; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin A Receptor Antagonists; Endothelium; Fibrosis; Humans; Inflammation; Kidney; Kidney Glomerulus; Macrophages; Male; Mice; Mice, Knockout; Thrombomodulin | 2021 |
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
Topics: Animals; Atrasentan; Disease Models, Animal; Doxorubicin; Endothelin A Receptor Antagonists; Fibrosis; Gene Expression; Kidney Diseases; Kidney Glomerulus; Male; Mice; Podocytes; Proteinuria; Pyrrolidines; Receptor, Endothelin A | 2013 |
Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Atrasentan; Blood Pressure; Desoxycorticosterone Acetate; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression Regulation; Hypertension; Kidney; Male; Proteinuria; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Sodium Chloride, Dietary | 2014 |
Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
Topics: Allopurinol; Analysis of Variance; Animals; Antioxidants; Atrasentan; Biomarkers; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gout Suppressants; Hypertrophy, Left Ventricular; Hyperuricemia; Isoprostanes; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; RNA, Messenger; Spin Labels; Superoxides; Time Factors; Up-Regulation; Uric Acid; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling; Xanthine Oxidase | 2011 |
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Fibrosis; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Oxidative Stress; Pyrrolidines; Ramipril; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left; Ventricular Pressure | 2007 |
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Topics: Animals; Atrasentan; Blood Pressure; Collagen; Collagen Type I; Desoxycorticosterone; Endothelin A Receptor Antagonists; Fibrosis; Hypertension; Male; Myocardium; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |